Who Attends
Where Leaders Meet, and the Future Takes Shape.
Fierce Pharma Week is the premier gathering where life sciences decision-makers, innovators, and partners connect to accelerate the industry's future.
From C-suite executives to directors across marketing, communications, medical affairs, and commercialization, attendees represent the full spectrum of influence and expertise. Across four dynamic days, capital, innovation, and opportunity collide — driving meaningful conversations, breakthrough strategies, and lasting partnerships.
If you're not here, you're missing the conversations and connections that move the market forward.
Who Attends Fierce Pharma Week
1850+
Pharma Marketing Professionals
Primary Market Company Type
45% Pharma
6% Biotech
49% Agency
Job Level
33% C-Level/EVP/SVP/VP
46% Director
17% Manager
4% Other
300+
PR &
Communications
Primary Market Company Type
45% Pharma
10% Biotech
45% Agency
Job Level
44% C-Level/EVP/SVP/VP
44% Director
11% Manager
1% Other
400+
Commercialization
Experts
Primary Market Company Type
57% Pharma
31% Biotech
12% Agency
Job Level
30% C-Level/EVP/SVP/VP
54% Director
13% Manager
3% Other
450+
Medical Affairs Professionals
Primary Market Company Type
70% Pharma
16% Biotech
14% Agency
Job Level
25% C-Level/EVP/SVP/VP
55% Director
13% Manager
7% Other
You're in Good Company at Fierce Pharma Week!
Check Out This Sample of Who's Already Registered...
- Head of Omnichannel, US BBU, AstraZeneca
- Global Head, Regulatory Affairs, Advertising & Promotion, Allergan Aesthetics, Abbvie
- Chief Corporate Communications Officer, Alnylam Pharmaceuticals
- VP and Head of US Medical Affairs, Genmab
- VP, Omnichannel Operations, Astellas Pharma US
- Executive Director, Global Marketing & New Product Planning, Unicycive Therapeutics
- Assoc Director US Commercial Digital Enablement, CSL Behring
- Head of Digital Innovation & Marketing Operations, Azurity Pharmaceuticals
- Chief Strategy Officer and Head of Commercial, Bicycle Therapeutics
- SVP, Global Head, Corporate Affairs and Investor Relations, Galapagos
- Commercial Innovation HCP Product Lead, Pfizer
- SVP, Head US Medical Affairs, GSK
- National Field Marketing Lead, Takeda Oncology
- Director US HCP Marketing, Alexion Pharmaceuticals
- VP, Head of Medical Affairs, Takeda
- VP, Head of Medical Affairs Cell Therapy, BMS
- Director Omnichannel Innovation, AstraZeneca
- Director Programmatic & Paid Social, Bayer
- VP, Pipeline Commercialization Strategy, AbbVie
- Head of Omnichannel Marketing, Daiichi Sankyo
- Media Strategy, Johnson & Johnson
- Director Strategy and Outcomes Realization, Merck
- SVP, Worldwide Commercial Portfolio Strategy, BMS
- Director Digital Strategy Omnichannel Rheum, AbbVie
- Director Media Engagement, Genentech
- Sr Director Cross Brand Oncology Strategy, GSK
- Director US Oncology Omnichannel Strategy & Ops, Merck
- Vice President US Medical, Genentech
- Director HCP Marketing, Regeneron
- Director Omnichannel Analytics, Astellas
- Vice President, NA Communications, Bayer Pharmaceuticals
- Associate Director HCP Omnichannel Media, Eli Lilly
- Innovation Portfolio Peer to Peer Lead, UCB
- SVP, Corporate Affairs, Regeneron
- Associate Director of Omnichannel Media, Sanofi
- Team Lead, Uber Technologies
- Senior Director Global Marketing, Genmab
- VP Strategic Partnerships, Veradigm
- Director NA Omnichannel CRM Operations, Sanofi
- Director Digital Acceleration, AstraZeneca
- Sr Director Media, Bayer US LLC
- Global Head, Medical Affairs Excellence, Boehringer Ingelheim
- VP Head of Global Brand Marketing, Bayer AG
- Head Omnichannel Engagement Stategy, Novartis Pharmaceuticals Canada
- VP, Global Medical Affairs, Head of Medical Excellence in Oncology, AstraZeneca
- Senior Director Integrated Media Strategy, Pfizer